<SEC-DOCUMENT>0001842952-24-000078-index.html : 20240905
<SEC-HEADER>0001842952-24-000078.hdr.sgml : 20240905
<ACCEPTANCE-DATETIME>20240905080853
ACCESSION NUMBER:		0001842952-24-000078
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20240904
FILED AS OF DATE:		20240905
DATE AS OF CHANGE:		20240905

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Smith Karen L.
		CENTRAL INDEX KEY:			0001639637
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40654
		FILM NUMBER:		241279996

	MAIL ADDRESS:	
		STREET 1:		C/O JAZZ PHARMACEUTICALS PLC
		STREET 2:		5TH FL, WATERLOO EXCHANGE, WATERLOO RD
		CITY:			DUBLIN L2 4
		STATE:			L2
		ZIP:			0

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Context Therapeutics Inc.
		CENTRAL INDEX KEY:			0001842952
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				863738787
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		2001 MARKET STREET
		STREET 2:		SUITE 3915 UNIT #15
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19103
		BUSINESS PHONE:		267-225-7416

	MAIL ADDRESS:	
		STREET 1:		2001 MARKET STREET
		STREET 2:		SUITE 3915 UNIT #15
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Context Therapeutics LLC
		DATE OF NAME CHANGE:	20210128
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>wk-form3_1725538127.xml
<DESCRIPTION>FORM 3
<TEXT>
Document 1 - file: wk-form3_1725538127.html

Document 1 - RAW XML: wk-form3_1725538127.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>context-karenlsmithsection.htm
<DESCRIPTION>EX-24
<TEXT>
Document 2 - file: context-karenlsmithsection.htm

</DOCUMENT>
</SEC-DOCUMENT>